Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NuVasive Expands its Advanced Materials Science(TM) Portfolio to Offer Porous Titanium Spine Implants for all TLIF Procedures

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial...

NUVA : 64.90 (+1.41%)
Edwards Lifesciences' (EW) SAPIEN 3 TAVR Receives FDA Nod

Edwards Lifesciences (EW) plans a commercial introduction of SAPIEN 3 Ultra in Europe.

EW : 225.38 (+1.29%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now

Investor confidence continues to be high on Omnicell's (OMCL) prospects.

OMCL : 71.06 (+0.41%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results

The study outcome has been a major step for QIAGEN (QGEN) toward offering accurate diagnosis and treatment of gastroenteritis.

NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
QGEN : 34.22 (-1.69%)
MDT : 108.85 (+4.48%)
Baxter's PrisMax Adopted by Hamilton Health Care System

Baxter's (BAX) PrisMax System first adopted by Hamilton Health, which in turn is expected to enhance patient care.

SYK : 220.07 (+0.65%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
HAE : 135.82 (-0.56%)
CVS Health Banks on Health Care Benefit Prospects Amid Woes

CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition is gaining a strong momentum.

CVS : 61.55 (+0.26%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
ResMed (RMD) Hits a New 52-Week High: What's Driving It?

ResMed (RMD) gains from promising financial results in the fourth quarter of fiscal 2019.

NUVA : 64.90 (+1.41%)
RMD : 136.39 (+0.29%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
Here's Why You Should Hold Onto Insulet (PODD) Stock for Now

Investor confidence continues to be high on Insulet's (PODD) solid prospects.

NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
PODD : 153.93 (+0.91%)
MDT : 108.85 (+4.48%)
NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone...

NUVA : 64.90 (+1.41%)
Boston Scientific Rides on New Products Amid Dull Pacer Sales

Within MedSurg, Boston Scientific (BSX) is on track for the year-end launch of Exalt-D Single-Use Duodenoscope, which is used in ERCP procedures.

BSX : 42.92 (+0.42%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
Baxter (BAX) Hits 52-Week High, Can the Run Continue?

Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

EYE : 27.80 (+1.09%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
Canopy Growth Set to Acquire Beckley Canopy Therapeutics

With the Beckley Canopy Therapeutics acquisition, Canopy Growth's (CGC) research and development endeavors would be expanding worldwide, thereby making the company a global pioneer in cannabinoid research....

NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
MDT : 108.85 (+4.48%)
CGC : 27.24 (+1.95%)
National Vision (EYE) Q2 Earnings Lag Estimates, Margins Down

National Vision's (EYE) Military brand registers robust growth while other brands fail to impress.

EYE : 27.80 (+1.09%)
SYK : 220.07 (+0.65%)
NUVA : 64.90 (+1.41%)
LMAT : 31.18 (-1.02%)
Haemonetics (HAE) Beats on Q1 Earnings, Raises '19 EPS View

Haemonetics (HAE) Q1 performance by all business sections has been impressive, except for BloodCenter.

SRDX : 46.56 (+1.48%)
NUVA : 64.90 (+1.41%)
LMAT : 31.18 (-1.02%)
HAE : 135.82 (-0.56%)
NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today is hosting its 2019 Investor...

NUVA : 64.90 (+1.41%)
NUVA vs. RMD: Which Stock Is the Better Value Option?

NUVA vs. RMD: Which Stock Is the Better Value Option?

NUVA : 64.90 (+1.41%)
RMD : 136.39 (+0.29%)
Will NuVasive Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor NuVasive.

NUVA : 64.90 (+1.41%)
Nuvasive Inc Rises 2.37% on Heavy Volume: Watch For Potential Pullback

Nuvasive Inc (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $56.52 to a high of $65.99. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $63.39...

NUVA : 64.90 (+1.41%)
Watch for Nuvasive Inc to Potentially Pullback After Gaining 2.37% Yesterday

Nuvasive Inc (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $56.52 to a high of $65.99. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $63.39...

NUVA : 64.90 (+1.41%)
NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q2

NuVasive (NUVA) witnesses balanced revenue growth across majority of key operating segments.

SYK : 220.07 (+0.65%)
NUVA : 64.90 (+1.41%)
BAX : 87.96 (+0.10%)
ISRG : 498.86 (+0.68%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
AIZ -0.16 , WELL -0.06 , SBAC +1.27 , CCI +0.62 , SO -0.13
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar